Anvimo 240 Tablet is an antiviral medicine used to prevent and control cytomegalovirus (CMV) infection, especially in transplant patients with weakened immune systems. It works by blocking a key viral enzyme, stopping the virus from multiplying and reducing the risk of complications.
Anvimo 240 Tablet can be taken with or without food at the same time each day for the full duration recommended.. Do not skip doses or stop early, as this may lead to viral resistance and reduced effectiveness. If you miss a dose, take it as soon as possible unless it is near the next scheduled dose.
Common side effects of Anvimo 240 Tablet include nausea, diarrhea, vomiting, cough, headache, and abdominal pain. If any of these side effects persist or worsen, discuss them with your doctor. They may be able to provide supportive treatments or adjust your dosage.
Anvimo 240 Tablet should be used with caution in individuals with liver or kidney problems. Inform your doctor if you have any allergies or are taking medications as they may interfere with its effectiveness. Pregnant and breastfeeding women should consult their doctor before taking this medicine to make sure it is safe for them.
Anvimo 240 Tablet helps protect against cytomegalovirus (CMV) infection, especially in individuals with weakened immune systems, such as transplant patients. It prevents the virus from multiplying, reducing the risk of serious complications, supporting recovery, and helping maintain overall health.
Side effects of Anvimo Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Anvimo
Nausea
Diarrhea
Vomiting
Peripheral edema
Cough
Fatigue
Headache
Abdominal pain
How to use Anvimo Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Anvimo 240 Tablet may be taken with or without food.
How Anvimo Tablet works
Anvimo 240 Tablet is an antiviral medicine. It works by blocking the CMV DNA terminase complex, an enzyme needed for the virus to multiply and spread. It prevents viral replication and helps control CMV infection, reducing the risk of complications, especially in people with weakened immune systems, such as transplant patients.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Anvimo 240 Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Anvimo 240 Tablet during pregnancy is not available. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Anvimo 240 Tablet may be safe to use during breastfeeding. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Driving
CONSULT YOUR DOCTOR
It is not known whether Anvimo 240 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
Kidney
CONSULT YOUR DOCTOR
There is limited data available on the use of Anvimo 240 Tablet in patients with kidney disease. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Anvimo 240 Tablet is probably safe to use in patients with liver disease. Limited data suggest dose adjustment may not be needed.
What if you forget to take Anvimo Tablet?
If you miss a dose of Anvimo 240 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
Always take Anvimo 240 Tablet exactly as directed by your doctor. Stopping early or skipping doses can increase the risk of CMV infection recurrence.
Anvimo 240 Tablet may interact with immunosuppressants, anticoagulants, and other medications. Always inform your doctor about any drugs or supplements you are taking.
Patients with liver or kidney disease should use Anvimo 240 Tablet with caution. Regular monitoring may be required to adjust the dose safely.
Anvimo 240 Tablet may cause nausea, headache, or fatigue. Inform your doctor if any side effects persist or worsen.
Fact Box
Chemical Class
Phenylpiperazines
Habit Forming
No
Therapeutic Class
ANTI INFECTIVES
Action Class
Antiviral Agents (Non-HIV)
FAQs
How long do I need to take Anvimo 240 Tablet?
The duration depends on your condition and risk of CMV infection. Follow your doctor’s instructions carefully.
Is Anvimo 240 Tablet a cure for cytomegalovirus (CMV) infection?
No, Anvimo 240 Tablet does not cure CMV infection. It helps prevent the virus from multiplying, reducing the risk of complications, especially in transplant patients.
What happens if CMV becomes resistant to Anvimo 240 Tablet?
If CMV develops resistance, Anvimo 240 Tablet may become less effective. Your doctor may recommend alternative treatments or a combination approach.
Can I stop taking Anvimo 240 Tablet if I feel better?
No. Complete the full course as prescribed by your doctor. Stopping early can lead to viral resistance and the recurrence of infection.
Can Anvimo 240 Tablet interact with other medications?
Yes, Anvimo 240 Tablet may interact with medications that affect the CYP3A enzyme. Inform your doctor about all medicines you are taking.
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
References
Letermovir [Product Information]. Rahway, NJ: Merck Sharp & Dohme LLC; 2025. [Accessed 26 Mar. 2025] (online) Available from:
Letermovir [Product Information]. Kirkland, QC: Merck Canada Inc.; 2017. [Accessed 26 Mar. 2025] (online) Available from:
Letermovir [Product Information]. Newmarket Auckland: Merck Sharp & Dohme (New Zealand) Ltd; 2021. [Accessed 26 Mar. 2025] (online) Available from:
Marketer details
Name: Zydus Lifesciences Ltd
Address: Zydus Corporate Park, 4Th Floor, B Wing, Plot No 103, Near Nirma University,S G Highway, Ahmedabad, 382481 / Scheme No. 63, Survey No. 536, Khoraj(Gandhinagar), Near Vaishnodevi Circle, Ahmedabad - 382481, Gujarat.